Immatics أخبار Eulerpool

Immatics إيولربول AFX

أخبار سهم Immatics

يتابع Immatics العديد من الصحفيين والمستثمرين حول العالم. نقدم هنا أحدث أخبار Immatics.

• ١٦ سبتمبر ·

  Yahoo
  Immatics Presents Clinical Proof-of-Concept Data from Ongoing Phase 1 Dose Escalation Trial with TCR Bispecific Molecule TCER® IMA401 Targeting MAGEA4/8 at ESMO 2024 and Provides Development Update
• ١٦ سبتمبر ·

  TipRanks
  Immatics Reveals Promising IMA401 Trial Results
• ١٦ سبتمبر ·

  GlobeNewswire
  Immatics Presents Clinical Proof-of-Concept Data from Ongoing Phase 1 Dose Escalation Trial with TCR Bispecific Molecule TCER? IMA401 Targeting MAGEA4/8 at ESMO 2024 and Provides Development Update
• ١٦ سبتمبر ·

  Thefly.com
  Immatics collaboration with Bristol Myers ends due to portfolio prioritization
• ١٦ سبتمبر ·

  Thefly.com
  Immatics presents TCER IMA401 data at ESMO
• ٦ سبتمبر ·

  Yahoo
  Immatics Announces Upcoming Oral Presentation at the Society for Melanoma Research Congress 2024
• ٢٢ أغسطس ·

  Market News Video
  IMTX Makes Notable Cross Below Critical Moving Average
• ١٦ أغسطس ·

  TipRanks
  Buy Rating for Immatics: Promising Clinical Trials and Strong Financials Signal Upside Potential
• ١٦ أغسطس ·

  TipRanks
  Buy Rating Justified by Immatics’ Advancing Pipeline and Strategic Financial Position
• ١٥ أغسطس ·

  Yahoo
  Immatics Second Quarter 2024 Earnings: Beats Expectations